Back
Movado Group 10K Form
Sell
33
MOV
Movado Group
Last Price:
19.32
Seasonality Move:
3.45%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-30 | 10Q | MOV/Movado Group Quarterly |
2023-11-30 | 10Q | MOV/Movado Group Quarterly |
2023-08-24 | 10Q | MOV/Movado Group Quarterly |
2023-05-25 | 10Q | MOV/Movado Group Quarterly |
2022-11-22 | 10Q | MOV/Movado Group Quarterly |
2022-08-25 | 10Q | MOV/Movado Group Quarterly |
Receive MOV News And Ratings
See the #1 stock for the next 7 days that we like better than MOV
MOV Financial Statistics
Sales & Book Value
Annual Sales: | $672.6M |
---|---|
Cash Flow: | $-20.16M |
Price / Cash Flow: | 18.26 |
Annual Sales: | $22.69 |
Price / Book: | 0.85 |
Profitability
EPS (TTM): | 1.59000 |
---|---|
Net Income (TTM): | $36.15M |
Gross Margin: | $370.39M |
Return on Equity: | 7.13% |
Return on Assets: | 4.77% |
Movado Group Earnings Forecast
Key Movado Group Financial Ratios
- The Gross Profit Margin over the past 32 years for MOV is 55.07%.
- The Selling, General & Administrative Expenses for MOV have been equal to 46.94% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 1.06% of Operating Income.
- The Net Earning history of MOV is 6.94% of Total Revenues.
- Per Share Earnings over the last 32 years have been positive in 17 years.
Movado Group Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Textiles, Apparel & Luxury Goods |
Sector: | Consumer Discretionary |
Current Symbol: | MOV |
CUSIP: | 624580 |
Website: | movadogroup.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 4.41 |
Quick Ratio: | 2.7 |
Price-to-Earnings
Trailing P/E Ratio: | 9.37 |
---|---|
Forward P/E Ratio: | 0 |
MOV Technical Analysis vs Fundamental Analysis
Sell
33
Movado Group (MOV)
is a Sell
Is Movado Group a Buy or a Sell?
-
Movado Group stock is rated a Sell
The current Movado Group [MOV] share price is $19.30. The Score for MOV is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.